Eloxx Pharmaceuticals (ELOX) News Today $0.0002 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Eloxx Pharmaceuticals (OTC:ELOX) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comEloxx Pharmaceuticals Provides Pipeline and Financing UpdatesJuly 11, 2024 | globenewswire.comEloxx Pharmaceuticals Inc (ELOX)April 24, 2024 | investing.comDelveInsight Business Research, LLP: Alport Syndrome Market to Witness Upsurge in Growth at a Massive CAGR of 69% by 2034 | DelveInsightApril 17, 2024 | finanznachrichten.deAlport Syndrome Market to Witness Upsurge in Growth at a Massive CAGR of 69% by 2034 | DelveInsightApril 17, 2024 | finance.yahoo.comEloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program UpdatesApril 16, 2024 | globenewswire.comGene therapy and glycoside drugs offer new hope for polycystic kidney disease treatmentApril 5, 2024 | msn.comNasdaq Inc. Buy Rating: EPS Growth, Valuation Expansion, and Strong FinTech ProspectsMarch 26, 2024 | markets.businessinsider.comAlmirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological DiseasesMarch 13, 2024 | finanznachrichten.deAlmirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseasesMarch 13, 2024 | globenewswire.comAlmirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological DiseasesMarch 13, 2024 | businesswire.comEloxx Pharmaceuticals Stock (OTC:ELOX), Short Interest ReportFebruary 22, 2024 | benzinga.comVertex Pharmaceuticals Inc.February 16, 2024 | barrons.comEloxx Pharmaceuticals, Inc. (ELOX)February 6, 2024 | finance.yahoo.comCNS Pharmaceuticals prices $4M public offeringJanuary 30, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Regeneron (REGN)December 23, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Annexon Biosciences (ANNX) and United Therapeutics (UTHR)December 21, 2023 | markets.businessinsider.comOff the Beaten Path: 3 Delisted Stocks for The Speculative InvestorDecember 13, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Lumos Pharma (LUMO), Crispr Therapeutics AG (CRSP) and Biomea Fusion (BMEA)December 11, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Biomea Fusion (BMEA) and Medtronic (MDT)November 22, 2023 | markets.businessinsider.comHoth stock jumps on positive FDA feedback on drug HT-KITNovember 14, 2023 | msn.comEloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business UpdateNovember 13, 2023 | finance.yahoo.comEloxx Pharmaceuticals Inc ELOXNovember 8, 2023 | morningstar.comEloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of ProteinuriaOctober 9, 2023 | finance.yahoo.comEloxx Pharmaceuticals prices $2M stock offeringSeptember 21, 2023 | seekingalpha.comEloxx Pharmaceuticals Announces Registered Direct Offering - Quick FactsSeptember 19, 2023 | markets.businessinsider.comEloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesSeptember 19, 2023 | finance.yahoo.comEloxx Pharmaceuticals Reports Independent Confirmation of Positive Biopsy Results in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport SyndromeSeptember 18, 2023 | finance.yahoo.comEloxx moves ahead with plans with gene therapy for rare kidney disorderSeptember 8, 2023 | msn.comEloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013September 7, 2023 | finance.yahoo.comEloxx Pharmaceuticals (NASDAQ: ELOX)August 30, 2023 | fool.comEloxx reports all patients in Phase II Alport syndrome trial have improvedAugust 15, 2023 | msn.comEloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business UpdateAugust 14, 2023 | markets.businessinsider.comEloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport SyndromeAugust 14, 2023 | finance.yahoo.comEloxx Pharma (NASDAQ:ELOX) Rises On Promising Phase 2 Data In Alport SyndromeAugust 14, 2023 | msn.comEloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport SyndromeAugust 14, 2023 | finance.yahoo.comThis Small Cap Stock Surged Over 100%Shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) rocketed almost 100% on Tuesday after receiving an increased price target from Oppenheimer.July 12, 2023 | marketbeat.comEloxx, Airbnb, Tesla, PainReform, Roku: Why These 5 Stocks Are Drawing Investor Attention TodayJuly 11, 2023 | msn.comEloxx Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 111.3%July 11, 2023 | benzinga.comOppenheimer Maintains Eloxx Pharmaceuticals (ELOX) Outperform RecommendationJuly 11, 2023 | msn.comTrading was temporarily halted for "ELOX" at 03:07 PM with a stated reason of "LULD pause."July 11, 2023 | marketbeat.comWhy Eloxx Pharmaceuticals (ELOX) Stock Is Soaring TuesdayJuly 11, 2023 | benzinga.comOppenheimer Maintains Outperform on Eloxx Pharmaceuticals, Raises Price Target to $55July 11, 2023 | benzinga.comTrading was temporarily halted for "ELOX" at 10:07 AM with a stated reason of "LULD pause."July 11, 2023 | marketbeat.comTrading was temporarily halted for "ELOX" at 09:07 AM with a stated reason of "LULD pause."July 11, 2023 | marketbeat.comEloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic BenefitJuly 10, 2023 | finance.yahoo.comEloxx Pharmaceuticals Key Opinion Leader Event Highlights Significant Unmet Need in Treatment of Alport Syndrome Patients with Nonsense Mutations and Additional Positive Results from Phase 2 Clinical Study Evaluating ELX-02June 28, 2023 | finance.yahoo.comEloxx Pharmaceuticals to Host Investor and Analyst Call on Alport SyndromeJune 21, 2023 | finance.yahoo.comEloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA CongressJune 21, 2023 | finance.yahoo.comFinal Data Report: Eloxx Touts Improved Lung Function For Cystic Fibrosis CandidateJune 15, 2023 | benzinga.com Get Eloxx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter. Email Address Countdown to the biggest trade of my 25 yr career (Ad)Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025. Click here to see the surprising reason why ELOX Media Mentions By Week ELOX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELOX News Sentiment▼0.000.43▲Average Medical News Sentiment ELOX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELOX Articles This Week▼00▲ELOX Articles Average Week Get Eloxx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VectivBio News Today Pieris Pharmaceuticals News Today Luna Innovations News Today Precigen News Today Anavex Life Sciences News Today PTC Therapeutics News Today Amgen News Today Gilead Sciences News Today argenx News Today Biogen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELOX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eloxx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eloxx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
